Home | Welcome to Contract Pharma   
Last Updated Wednesday, April 23 2014
Print RSS Feed

Breaking News

August 1, 2013
Revenues up 3% in the quarter  Read More »
August 1, 2013
Product development revenues up 5% in the quarter  Read More »
August 1, 2013
Revenues up 6% in the quarter  Read More »
August 1, 2013
Generic competition, Brazil issue impact results  Read More »
August 1, 2013
Generic erosion impacts results  Read More »
August 1, 2013
Pfizer, Nycomed settlement wallops results  Read More »
August 1, 2013
To provide process and method development, scale-up, clinical supply for rare disease therapy   Read More »
July 31, 2013
Recognized by Otsuka for clinical supply services  Read More »
July 31, 2013
Will focus on discovery of new pain treatments  Read More »
July 31, 2013
Revenues up 5% in the quarter  Read More »
July 31, 2013
Late-Stage revenues up 17% in the quarter  Read More »
July 31, 2013
Revenues up 11% driven by Botox  Read More »
July 31, 2013
Gains third-party cGMP certification as excipients provider  Read More »
July 30, 2013
Expands oncology expertise  Read More »
July 30, 2013
Development program to target novel inflammation pathway  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On